SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-006085
Filing Date
2020-01-23
Accepted
2020-01-23 08:38:27
Documents
2
Period of Report
2020-01-16
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm205656-1_8k.htm 8-K 20862
2 EXHIBIT 99.1 tm205656d1_ex99-1.htm EX-99.1 16681
  Complete submission text file 0001104659-20-006085.txt   38834
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 20540514
SIC: 2834 Pharmaceutical Preparations